BODALCHEM Bodal Chemicals Q1 FY26 results (Apr–Jun 2025) and concall
Bodal Chemicals reported an 8% YoY revenue growth to ₹458 crores and a 40% YoY EBITDA growth to ₹52 crores in Q1 FY26, driven by better realizations. While the new benzene derivatives project added to overheads and faced margin pressure, the company is focused on improving utilization and debt reduction. Dye Intermediates and Dyestuff segments saw revenue degrowth, but Basic Chemicals and Chlor Alkali showed positive growth.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 429 | 443 | 451 | 454 |
| EBITDA | 33 | 44 | 47 | 48 |
| Net profit | 0 | 5 | 14 | 10 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
